ストックスクリーナーアプリを入手
9.28
10.34%
-1.07
Recursion Pharmaceuticals Inc (RXRX) 最新ニュース
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite? - MSN
Top Biotech Stocks To ConsiderFebruary 20th - MarketBeat
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite? - MarketBeat
Cathie Wood Explains Why She Likes Recursion Pharmaceuticals, Inc. (RXRX) - MSN
Biotech Stocks Worth WatchingFebruary 15th - MarketBeat
Why Recursion Pharmaceuticals, Inc. (RXRX) is the Best Performing Healthcare Stock So Far in 2025 - MSN
Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult - MedCity News
Backed by Recursion CEO, Altitude Lab venture aims to fill gap from NIH cuts - MM+M Online
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Recursion CEO launches pre-seed fund in response to NIH cuts - BioPharma Dive
Why Jensen Huang’s Company Is Betting On Recursion Pharmaceuticals, Inc. (RXRX) - MSN
Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City - The Manila Times
Can This New Biotech Fund Save 1,500 Startups Hit by SBIR Changes? - StockTitan
Could this Nvidia-backed growth stock be a millionaire-maker at $10? - Yahoo Finance UK
Recursion CEO: Publicly funded research built the biopharma industry. Now it needs our help - STAT
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday - MSN
Recursion Pharmaceuticals Stock Scores RS Ratings Over 90 - MSN
5 Stocks Jensen Huang’s Company is Betting On - Insider Monkey
Recursion Pharmaceuticals Before Q4 Earnings: How to Play the Stock - MSN
Altitude Lab's Startup Portfolio Hits $154M Milestone: Inside the Biotech Incubator's Success Story - StockTitan
25 Top AI Stocks That Could Boost Your Portfolio - The Motley Fool
SoftBank Joins Nvidia In Backing Recursion Pharma, Retail Traders Rally Behind Stock Surge - NewsBreak
Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype - MSN
Best Biotech Stocks To Keep An Eye OnFebruary 14th - MarketBeat
Promising Mid Cap Stocks To Add to Your WatchlistFebruary 16th - MarketBeat
The Rise of Recursion Pharmaceuticals: A Biotech Stock on the Move - RagingBull
Promising Biotech Stocks To Follow NowFebruary 17th - MarketBeat
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared Last Week - MSN
SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals - MSN
Recursion Pharmaceuticals (NASDAQ: RXRX) Surges Nearly 24% as Nvidia Retains Stake – market - HPBL
Recursion Pharmaceuticals Stock Soars as Nvidia Maintains Stake – A Vote of Confidence? – market - HPBL
Recursion Pharmaceuticals (RXRX) Sees Institutional Investors Adjust Positions Amid Market Volatility - HPBL
Institutional Investors Bet Big on Recursion Pharmaceuticals (RXRX) Amid Growing Biotech Interest - HPBL
Why Recursion Pharmaceuticals (RXRX) Skyrocketed 23.88% on Friday – market - HPBL
Recursion Pharmaceuticals (RXRX): A Biotech Stock Outpacing the Market with Explosive Growth - HPBL
Recursion Pharmaceuticals (RXRX) Stock Surges 15%: Nvidia’s Vote of Confidence Sparks AI Biotech Rally - HPBL
Recursion Pharmaceuticals Stock Surges 15.8% as Nvidia Retains Stake – market - HPBL
Mirae Asset Global Investments Co. Ltd. Sells 74,818 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - MarketBeat
Shares of 10 Firms Soar on Friday - Insider Monkey
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 8.6%What's Next? - MarketBeat
Why Recursion Pharmaceuticals Inc. (RXRX) Soared on Friday? - MSN
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading 8.6% HigherWhat's Next? - MarketBeat
Recursion Pharmaceuticals (RXRX) Laps the Stock Market: Here's Why - MSN
Best Mid Cap Stocks To Follow TodayFebruary 14th - MarketBeat
Why Recursion Pharmaceuticals Stock Is Soaring Today - MSN
Best Pharmaceutical Stocks To Watch NowFebruary 14th - MarketBeat
Cathie Wood Doubles Down on 3D Systems, Blade Air Mobility, and Recursion Pharmaceuticals: Key Moves for Ark Invest – market - HPBL
SoftBank Latest Moves: Major Stakes in PacBio, Recursion Pharmaceuticals and Better Home & Finance - HPBL
Recursion Pharmaceuticals (RXRX) Stock Soars 15.8%, Nvidia Confidence Boosts Investor Sentiment - HPBL
Recursion Pharmaceuticals Soars 15.8% Amid Nvidia Confidence Boost – market - HPBL
Why Recursion Pharmaceuticals (RXRX) Stock Soared 15.8% Today – Is Nvidia’s Confidence a Game Changer? - HPBL
Recursion Pharmaceuticals Sees Significant Stock Surge Amid Analyst Activity and Institutional Interest - HPBL
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):